EP225 (Ephed asthma ephedrine hydrochloride 25 mg / guaifenesin 200 mg)
Pill imprint EP225 has been identified as Ephed asthma ephedrine hydrochloride 25 mg / guaifenesin 200 mg.
Ephedrine/guaifenesin is used in the treatment of cold symptoms and belongs to the drug class upper respiratory combinations. FDA has not classified the drug for risk during pregnancy. Ephedrine/guaifenesin ephedrine hydrochloride 25 mg / guaifenesin 200 mg is not a controlled substance under the Controlled Substance Act (CSA).
More about ephedrine/guaifenesin
- Side Effects
- Drug Interactions
- Support Group
- 7 Reviews – Add your own review/rating
- Drug class: upper respiratory combinations
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.